Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.
about
Non-natural and photo-reactive amino acids as biochemical probes of immune functionCa2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell DeterminantPhosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopesStructures of native and affinity-enhanced WT1 epitopes bound to HLA-A0201: Implications for WT1-based cancer therapeuticsStructure and receptor-binding properties of an airborne transmissible avian influenza A virus hemagglutinin H5 (VN1203mut)Class I Major Histocompatibility Complex, the Trojan Horse for Secretion of Amyloidogenic β 2 -MicroglobulinAn airborne transmissible avian influenza H5 hemagglutinin seen at the atomic levelStructural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen AllelesDependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function.The cellular redox environment alters antigen presentationTumors reveal their secrets to cytotoxic T cells.MHC-bound antigens and proteomics for novel target discovery.Structural and kinetic basis for heightened immunogenicity of T cell vaccines.Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine designAccurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens.Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.Peptidomimetics: modifying peptides in the pursuit of better vaccines.Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines.DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1.Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus.
P2860
Q21144124-657309F8-FF8F-4ED5-B401-2627225E06AFQ27646628-104E2322-50A4-4E68-87EC-AE6D2D92595CQ27652640-0B9891C1-1467-42D7-A502-80FB965ACE29Q27653670-5CDF37E3-B757-4FB2-9C59-DE193C2B4072Q27663300-18208171-242C-433D-8D68-3A4468DF9026Q27678747-682BD258-CD32-401E-8991-9560516D150DQ27680885-372C91A1-5B36-421C-9D97-8162459FE399Q27684542-3A794881-F56F-4BB1-B50F-479688475C21Q27703610-A9170DC7-6EB3-4FDA-BA3C-CE84789507D9Q33821395-E993234E-A647-4BDC-A585-BC4713283BFAQ34037944-90C3EFCA-0D39-41A0-98A2-4BF3E9009AA6Q34283588-CF0BBD0B-6EE9-4022-8CB4-5429EF7AFE47Q35075389-46742723-6863-4D94-9546-2E7CEEEC2357Q35911151-E08EC853-D573-4703-8886-5AF36BA4E7E2Q36403443-78ECFB53-31AC-4085-9B9F-60E25F53803AQ36456760-350830B8-3171-450F-B594-AED4568027AAQ36941362-A251F59C-4EEC-4AB8-AD85-1FFFA9973F22Q37107843-18E1A440-7345-4D77-938B-06C238D2C285Q37272711-C2A71BEF-EF1A-4BA5-AEF9-1565BE277CA7Q37844539-0BF3F070-5261-48F7-84F2-C53F80C13427Q38721030-F6088777-83F1-4B23-B6DF-F2C29FA13100Q40321837-A5B64FB2-4912-4960-9DA2-20703CB3D5ACQ47881534-800DEF02-CBB1-4882-830B-DA9069819694Q51075893-591045D4-CE7E-4DA9-B2C0-3239670EBB95Q51825111-C74210C2-92DB-4226-9CDB-43BFC7F7E542Q52804789-BAF555C8-DCB9-44C3-B2A2-696F828CD048
P2860
Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Functional and structural char ...... a novel immunogenic analogue.
@en
Functional and structural char ...... a novel immunogenic analogue.
@nl
type
label
Functional and structural char ...... a novel immunogenic analogue.
@en
Functional and structural char ...... a novel immunogenic analogue.
@nl
prefLabel
Functional and structural char ...... a novel immunogenic analogue.
@en
Functional and structural char ...... a novel immunogenic analogue.
@nl
P2093
P2860
P50
P356
P1476
Functional and structural char ...... a novel immunogenic analogue.
@en
P2093
Andrew I Webb
Heather Jackson
Lars Kjer-Nielsen
Linus Chang
Qiyuan Chen
Weisan Chen
P2860
P304
23438-23446
P356
10.1074/JBC.M314066200
P407
P50
P577
2004-03-05T00:00:00Z